                </a></li></ul></div><p><strong>Figure 4.  <span>Triggering TLR8 or 7/8 results in strong activation of NK and CD8+ T-cells.</span></strong></p><a id="article1.body1.sec2.sec3.fig2.caption1.p1" name="article1.body1.sec2.sec3.fig2.caption1.p1"></a><p>PBMC were treated with the TLR agonists and 24 h later analyzed for intracellular IFN-γ, TNF-α and CD107a expression for CD8+ T-cells (A) and NK (B), for the expression of CD69 on NK cells (n = 3) (C) and for the NKs' cytolytic activity against K562 cells (n = 3) (D). Data were first analyzed by one-way analysis of variance and if tested significantly different, by Bonferroni's multiple comparison test.</p>
